National Cancer Institute; Notice of Closed Meetings, 14026 [2012-5695]
Download as PDF
14026
Federal Register / Vol. 77, No. 46 / Thursday, March 8, 2012 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 1, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–5700 Filed 3–7–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
wreier-aviles on DSK5TPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel;
Reprogramming, Aging and Alzheimer’s
Disease.
Date: March 27, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: DoubleTree by Hilton Hotel
Bethesda, 8120 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Elaine Lewis, Ph.D.,
Scientific Review Branch, National Institute
on Aging, Gateway Building, Suite 2C212,
MSC–9205, 7201 Wisconsin Avenue,
Bethesda, MD 20892, 301–402–7707,
elainelewis@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: March 1, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–5699 Filed 3–7–12; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
15:20 Mar 07, 2012
Jkt 226001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; MultiAnalyte Technologies for Cancer Biomarkers.
Date: March 26–28, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hilton Washington DC/Rockville
Hotel & Executive Meeting Center, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Zhiqiang Zou, MD, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Blvd., Room 8050A, MSC
8329, Bethesda, MD 20852, zouzhiq@mail.
nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Process
Analytic Technologies.
Date: April 3, 2012.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Thomas M. Vollberg,
Ph.D., Scientific Review Officer, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Boulevard,
Room 7142, Bethesda, MD 20892, 301–594–
9582, vollbert@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Prevention Research Small Grant Program
(R03).
Date: April 9–10, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Conference
& Center, 5701 Marinelli Road, Rockville, MD
20852.
Contact Person: Clifford W Schweinfest,
Ph.D., Scientific Review Officer, Special
PO 00000
Frm 00028
Fmt 4703
Sfmt 9990
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Blvd., Room
8050a, Bethesda, MD 20892–8329, 301–402–
9415, schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Immunotherapy.
Date: April 10, 2012.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Blvd., Room 7073, Rockville, MD
20852 (Telephone Conference Call).
Contact Person: Eun Ah Cho, Ph.D.,
Scientific Review Officer, Special Review &
Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Blvd., Suite 703, Room 7073,
Bethesda, MD 20892, 301–435–1822, choe@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Alternative
Affinity Capture Reagents for Cancer
Proteomics.
Date: April 25, 2012.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Health, 6116
Executive Blvd., Room 611, Rockville, MD
20852 (Telephone Conference Call).
Contact Person: Thomas A. Winters, Ph.D.,
Scientific Review Officer, Special Review &
Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 8146,
Bethesda, MD 20892–8329, 301–594–1566,
twinters@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/sep/sep.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: March 1, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–5695 Filed 3–7–12; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\08MRN1.SGM
08MRN1
Agencies
[Federal Register Volume 77, Number 46 (Thursday, March 8, 2012)]
[Notices]
[Page 14026]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-5695]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Multi-Analyte Technologies for Cancer Biomarkers.
Date: March 26-28, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: Hilton Washington DC/Rockville Hotel & Executive Meeting
Center, 1750 Rockville Pike, Rockville, MD 20852.
Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive Blvd.,
Room 8050A, MSC 8329, Bethesda, MD 20852, zouzhiq@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Process Analytic Technologies.
Date: April 3, 2012.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Thomas M. Vollberg, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive
Boulevard, Room 7142, Bethesda, MD 20892, 301-594-9582,
vollbert@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Prevention Research Small Grant Program (R03).
Date: April 9-10, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Conference & Center, 5701
Marinelli Road, Rockville, MD 20852.
Contact Person: Clifford W Schweinfest, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive Blvd.,
Room 8050a, Bethesda, MD 20892-8329, 301-402-9415,
schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Immunotherapy.
Date: April 10, 2012.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Blvd., Room
7073, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Eun Ah Cho, Ph.D., Scientific Review Officer,
Special Review & Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive Blvd.,
Suite 703, Room 7073, Bethesda, MD 20892, 301-435-1822,
choe@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Alternative Affinity Capture Reagents for Cancer Proteomics.
Date: April 25, 2012.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institute of Health, 6116 Executive Blvd., Room
611, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Thomas A. Winters, Ph.D., Scientific Review
Officer, Special Review & Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive
Boulevard, Room 8146, Bethesda, MD 20892-8329, 301-594-1566,
twinters@mail.nih.gov.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: March 1, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-5695 Filed 3-7-12; 8:45 am]
BILLING CODE 4140-01-P